T
Protara Therapeutics D
D
TARA
3.73500
USD
-0.22
(-5.44%)
مغلق
حجم التداول
5,360
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
129,823,035
المقالات
العنوان: Protara Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatmentoptions. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).